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osting by EAbstract This study was designed to evaluate effect of trigonelline and ethanol extract of Iraqi
Fenugreek seeds on oxidative stress in alloxan diabetic rabbits.
Oral dose of (10 mg/12 h) isolated trigonelline or (7.7 ml/12 h) of ethanol extract of Iraqi
Fenugreek seeds was administered to the rabbits for four weeks. Plasma malondialdehyde
(MDA) and glutathione (GSH), as oxidative stress markers were measured in all rabbits before
treatment and once weekly for four weeks after the treatment. The results showed a signiﬁcant
improvement in the stress induced oxidation parameters by alloxan-induced diabetes in rabbits.
The ethanol extract of Fenugreek seeds signiﬁcantly decreases the plasma malondialdehyde
(MDA) from 2.51 ± 0.34 lmol/l in diabetic control rabbits to 1.57 ± 0.12 lmol/l after four weeks
(P< 0.05). The plasma glutathione (GSH) level increases signiﬁcantly from 0.11 ± 0.02 lmol/l to
0.26 ± 0.02 lmol/l after four weeks of treatment of the ethanol extract (P< 0.05). The percent
reduction in plasma MDA level was 37.45%, while the percent elevation in plasma GSH was
136% after four weeks of treatment. The data showed that isolated trigonelline was less effective
than the ethanol extract of Fenugreek seeds in lowering plasma MDA or increasing the plasma
GSH markers. The results of this study clearly indicate that both ethanol extract of Fenugreek
and its major alkaloid, trigonelline are promising natural antioxidants and may be used in the treat-
ment of many diseases, especially diabetes mellitus.
ª 2012 University of Bahrain. Production and hosting by Elsevier B.V. All rights reserved.n 11196, Jordan. Tel.: +962
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lsevier1. Introduction
Antioxidants are of great importance because of their involve-
ment in decreasing the damages generated from free radicals,
that are naturally produced or associated with various diseases
such as cardiovascular diseases, diabetes mellitus, acute respi-
ratory distress syndrome, inﬂammatory diseases and cancer
(Young and Woodside, 2001; Maxwell, 1995; Kelly, 1998;
Aisling et al., 1996; Rahimi et al., 2005; Manson et al., 1993;
Guerrero et al., 2007; Toppo et al., 2009).
Fenugreek seeds are one of the important medicinal plants
which are widely used in folk medicine. It is known to have
diuretic, hypotensive, hypoglycemic and hypolipidemic effects
24 S.A. Hamadi(Newall et al., 1996; Ghosal et al., 1974; Ali and Azad-Khan
Hassan, 1995; Bordia et al., 1997). Trigonelline, major alkaloid
of Fenugreek seeds was reported to have a hypoglycemic effect
in normal and alloxan diabetic rabbits (Adeeb et al., 2002).
Shah et al. (2006) showed that the onset of action and maxi-
mum decrease in serum glucose were similar in glyburide and
trigonelline treated animals, but they differ in respect to the
mechanism of action. They proposed that the hypoglycemic ef-
fect of trigonelline due to enhanced pancreatic regeneration.
Fenugreek extracts were also reported to exhibit antioxidant
activity and could be used as a potent source of antioxidants
(Syeda et al., 2008).
The aim of this study is to evaluate the antioxidant effect of
isolated trigonelline and the ethanolic extract of Iraqi Fenu-
greek seeds in alloxan-induced diabetic rabbits.2. Material and methods
2.1. Materials
In this investigation, the ethanol extract of Fenugreek seeds
was prepared in our laboratories by reﬂuxing the defatted
Fenugreek seeds for 2 h and Trigonelline was isolated from
Fenugreek seeds according to the method of Adeeb et al.
(2002).
2.2. Experimental animals
2.2.1. Preparation of alloxan-diabetic rabbits
Fasting rabbits were made diabetic by a single intraperitoneal
dose of 75 mg/kg alloxanmonohydrate (Hopkins andWilliams,
England) dissolved in 1 ml normal saline. After 10 h, animals
received glucose water to avoid hypoglycemia. Diabetes was
conﬁrmed (after 24 h of alloxan injection) by the presence of
glucosuria using urine test tap (Glukotest) and by hyperglyce-
mia using Lab kit for glucose. Animals were left for four weeks
before starting the treatment. Experimental methods were
approved by the graduate study committee at the college of
pharmacy/University of Baghdad.
2.2.2. Experimental design
Thirty male albino rabbits weighing 1.36 kg ± 45g were used
in this study. They were classiﬁed into: group 1 (N= 10)
normal (non-diabetic) untreated rabbits; group 2 (N= 10)
diabetic rabbits received 10 mg/12 h of isolated trigonelline;
group 3 (N= 10) diabetic rabbits received 7.7 ml/12 h of
ethanol extract of Fenugreek seeds. Before treatment with eth-
anol extract or isolated trigonelline, diabetic rabbits (groups 2
& 3) received 7.7 ml distilled water orally twice daily for four
weeks and were considered as diabetic control. Fasting blood
samples were collected from the middle ear of these animals
once weekly for four weeks and analyzed for the determination
of glucose, malondialdehyde (MDA) and glutathione (GSH).
Then diabetic rabbits, groups 2 & 3 received the mentioned
dose of isolated trigonelline & ethanol extract of Fenugreek
seeds, respectively. Both types of treatment were administered
orally twice daily (every 12 h) for four weeks via oro-gastric
tube to avoid any rejection of the dose. Fasting blood samples
were collected from the middle ear artery at zero time (just be-
fore starting the treatment), and once weekly for four weeksand analyzed for the determination of glucose, malondialde-
hyde (MDA) and glutathione (GSH). The treatment period
with ethanol extract or trigonelline was four weeks. Xylol
was used to facilitate blood sampling.
2.2.3. Measurement of glucose levels
Glucose level was determined using the Lab kit for glucose.
According to the method of Barham and Trindoer, 1972, glu-
cose was measured after the enzymatic oxidation of glucose by
glucose oxidase to form hydrogen peroxide and gluconate.
Hydrogen peroxide then reacts with phenol and 4-aminophen-
azone in the presence of peroxidase to form quinonimine. The
absorbance at 505 nm was determined against blank reagent
and results expressed as mg/dl, based on the standard glucose
solution treated in the same manner. The test involved mixing
1 ml of the working reagent with 10 ll sample (or standard),
incubating the mixture for 10 min. at 37 C and the absorbance
was measured at 505 nm.
2.2.4. Measurement of plasma malondialdehyde (MDA) level
1.75 ml of saline azide was added to 0.25 ml of plasma and
mixed with 0.5 ml of H2O2 and 0.5 ml of 1% thiobarbituric
acid (TBA) in 0.05 M sodium hydroxide. The mixture was
incubated in a boiling water bath for 15 min to achieve color
development. The tubes were cooled under tap water and the
extent of MDA production was estimated from the absorbency
at 532 and 543 nm.
MDA concentration was calculated using a molar absorp-
tivity coefﬁcient of 1.56 · 105 M1 cm1 and the results were
expressed as micromole MDA/L (lmol/l) (Stocks and
Dormandy, 1971; Gilbert et al., 1984).
2.2.5. Measurement of plasma glutathione (GSH) level
0.5 ml of plasma was mixed with 0.5 ml of 3 mM 5,5, Dithiobis
(2-nitrobenzoic acid (DTNB) in phosphate buffer and 2.6 ml
of 0.1 M phosphate buffer (pH 8)). The absorbency of the
solution was measured at 412 nm during 2 min and the concen-
tration of GSH was calculated by comparison with a standard
curve prepared for this purpose (Goldin et al., 1988).
2.2.6. Statistical analysis
The data were statistically analyzed using the analysis of vari-
ance (ANOVA). Results were expressed as mean ± standard
error of mean (SEM). The results were considered signiﬁcant
with P< 0.05.
3. Results and discussion
Before treatment with ethanol extract of Fenugreek seeds or
isolated trigonelline, the results showed that the mean blood
glucose level in normal rabbits (group 1) was 98 ± 3.08 mg/dl
(5.44 ± 0.17 mmol/l) while in groups 2 & 3 (before treatment,
diabetic control) was 390 ± 15.41 mg/dl (21.66 ± 0.85 mmol/
l) & 381 ± 22 mg/dl (21.16 ± 1.22 mmol/l), respectively. Statis-
tical analysis showed that the mean blood glucose was increased
signiﬁcantly in diabetic control compared to group 1 (p< 0.05)
which conﬁrmed the state of diabetes that was induced by allox-
an dose. The data also showed that the mean ± SEM plasma
MDA and GSH in normal rabbits (group 1) were 1.13 ± 0.2
and 0.28 ± 0.03 lmol/L, respectively. The mean ± SEM plas-
Table 1 Effect of ethanol extract of Fenugreek seeds (7.7 ml/l2 h) on plasma MDA and GSH levels in alloxan diabetic rabbits.
Parameter Controlc group Diabeticd control Diabetic after treatment with ethanol extract of Fenugreek seed
1st week 2nd week 3rd week 4th week
MDAa 1.13 ± 0.2 2.51 ± 0.34* 2.52 ± 0.19 2.17 ± 0.23 1.96 ± 0.26 1.57 ± 0.12**
GSHb 0.28 ± 0.03 0.11 ± 0.02* 0.11 ± 0.05 0.18 ± 0.02 0.22 ± 0.03 0.26 ± 0.02**
a Plasma MDA (lmol/L) ± SEM.
b Plasma GSH (lmol/L) ± SEM.
c Control: normal rabbits (non-diabetic, group 1).
d Diabetic control (diabetic rabbits received distilled water).
* Signiﬁcant difference with respect to control group (P< 0.05).
** Signiﬁcant difference with respect to diabetic control (P< 0.05).
Table 2 Effect of isolated trigonelline (10 mg/l2 h) on plasma MDA and GSH levels in alloxan diabetic rabbits.
Parameter Controlc group Diabeticd control Diabetic after treatment with isolated trigonelline
1st week 2nd week 3rd week 4th week
MDAa 1.13 ± 0.2 2.28 ± 0.22* 2.26 ± 0.19 2.11 ± 0.25 1.35 ± 0.27 1.75 ± 0.15
GSHb 0.28 ± 0.03 0.16 ± 0.05* 0.16 ± 0.04 0.17 ± 0.03 0.17 ± 0.02 0.19 ± 0.01
a Plasma MDA (lmol/L) ± SEM.
b Plasma GSH (lmol/L) ± SEM.
c Control: normal rabbits (non-diabetic, untreated rabbits).
d Diabetic control (diabetic rabbits received distilled water).
* Signiﬁcant difference with respect to control group (P< 0.05).
Effect of trigonelline and ethanol extract of Iraqi Fenugreek seeds on oxidative stress in alloxan diabetic rabbits 25ma MDA, GSH in diabetic control rabbits were 2.51 ± 0.34,
0.11 ± 0.02 and 2.28 ± 0.22, 0.16 ± 0.05 lmol/L, respectively.
Statistical analysis showed that there was a signiﬁcant increase
in MDA and decrease in GSH level in diabetic control rabbits
compared to the normal rabbits (P< 0.05) which conﬁrmed
the state of oxidative stress in alloxan–induced rabbits as shown
in Tables 1 and 2.
The data showed that treatment with the ethanol extract of
Fenugreek seeds exhibited gradual reduction in plasma MDA
level during three weeks, while plasma GSH was gradually ele-
vated but it was not signiﬁcant during the three weeks of treat-
ment (Table 1). However, there was a signiﬁcant reduction
(p< 0.05) in plasma MDA and elevation (p< 0.05) in plasma
GSH level after four weeks of treatment compared to the dia-
betic control (pretreatment) as shown in Table 1. Trigonelline,
on the other hand gradually, reduced plasma MDA and ele-
vated plasma GSH after four weeks of treatment and these
changes in plasma MDA & GSH were not signiﬁcant
(p> 0.05) compared to diabetic control as shown in Table 2.Table 3 Percent of reduction in plasma MDA and elevation
in plasma GSH after four weeks of treatment with trigonelline
and ethanol extract of fenugreek seeds.











18.36% 136.36The changes in plasma level of MDA and GSH (increase in
MDA & decrease in GSH) represent 100% in diabetic control
rabbits due to the oxidative stress state that was induced by
alloxan dose. Therefore, the percent of reduction in plasma
MDA after four weeks of treatment with isolated trigonelline
or ethanol extract was calculated and presented in Table 3
and Fig. 1. Similarly, the percent of elevation in plasma
GSH after four weeks of treatment with isolated trigonelline
or ethanol extract is illustrated in Table 3 and Fig. 2. The data
in Table 3, Figs. 1 and 2, clearly showed that both isolated
trigonelline and ethanol extracts of Fenugreek seeds affect
the plasma level of MDA and GSH but the magnitude of
the effect is different. The effect of the ethanol extract of Fenu-
greek seeds was more (reduced plasma MDA level by 37.67%Figure 1 Percent of plasma MDA level decreased after four
weeks of treatment with 10 mg/12 h of isolated trigonelline (group
2) and 7.7 ml/12 h of ethanol extract of Fenugreek seeds (group 3)
in alloxan diabetic rabbits. Diabetic control: diabetic rabbits
without treatment.
Figure 2 Percent of plasma GSH level increased after four weeks
of treatment with 10 mg/12 h of isolated trigonelline (group 2) and
7.7 ml/12 h of ethanol extract of Fenugreek seeds (group 3) in
alloxan diabetic rabbits. Diabetic control: diabetic rabbits without
treatment.
26 S.A. Hamadiand elevated GSH level by 136.36%) than that of isolated
trigonelline, which only reduced plasma level of MDA by
23.24% & elevated plasma GSH level by 18.36.
The results of this study revealed that ethanol extract of
Fenugreek seeds had a signiﬁcant improvement (p< 0.05) in
the oxidative stress parameters which could be attributed to
the ﬂavonoid content of Fenugreek such as vexitin, isovexitin
and orientin.
Although, trigonelline also reduced oxidative stress markers
this improvement was not signiﬁcant (p> 0.05). This may be
due to the dose given or due to the short period of the study.
Fenugreek seeds have been reported to have antioxidant activ-
ity in vitro (Anuradha and Ravikumar, 1998; Hettiarachchy et
al., 1996)
The ethanol extract of Fenugreek seeds & isolated trigonel-
line reduced blood glucose and lipid proﬁle in alloxan-diabetic
rabbits (Adeeb et al., 2002). This effect may be explained in part
due to the antioxidant property of trigonelline because of its
structural similarity to nicotinamide which has an antioxidant
effect (Velikii et al., 1992). Furthermore, nicotinic acid, one of
the metabolite of trigonelline, also had an antioxidant effect.
In conclusion both, ethanol extract of Fenugreek and its
major alkaloid, trigonelline are promising natural antioxidants
and long trial period; different dose and total antioxidant sta-
tus (TAS) measurement may be needed in the future.
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